LED Medical Diagnostics Inc.

LED Medical Diagnostics Inc.

February 19, 2013 10:47 ET

LED Medical Diagnostics Obtains Listing on the Frankfurt Stock Exchange

BURNABY, BRITISH COLUMBIA--(Marketwire - Feb. 19, 2013) - LED Medical Diagnostics Inc. ("LED Medical", "the Company") (TSX VENTURE:LED)(FRANKFURT:LME) is pleased to announce that its common shares are now officially quoted on the Frankfurt Stock Exchange in the open market segment via the symbol "LME".

The Frankfurt Stock Exchange and the electronic trading platform provide a cost effective, efficient and transparent market for European investors to acquire and trade shares in LED Medical. "It opens up our company to a wide range of European investors that have a growing interest in medical technology," states Peter Whitehead, Founder and CEO of LED Medical. "This Frankfurt listing will provide visibility for the company in the broader, global investment community and will assist us as we strengthen our investor base in what is a large and liquid market."

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED-based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol "LED" as well as the Frankfurt Stock Exchange under the symbol "LME".

Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures the VELscope Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope Vx devices are now used to conduct more screenings for oral cancer and other oral diseases than any other adjunctive device. To date, there have been more than 12,000 VELscope Vx systems sold globally and they have been used to perform more than 25 million exams. For more information, visit www.leddental.com.

Forward Looking Information

This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Several factors could cause actual events or results to differ materially from those suggested by these forward-looking statements. Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2011. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • LED Medical Diagnostics Inc.
    Mark Komonoski, Investor Relations
    (403) 255-8483 or Toll-Free: (877) 255-8483
    Cell: (403) 470-8384
    Skype: mkomonoski